Pharmaceutical Industry in the
Canton of St. Gallen
47 companies in Pharmaceutical Industry based in the Canton of St. Gallen — name and year of registration from the commercial register. The list below shows them all.
All 47 companies in the Canton of St. Gallen
SCHOTT Pharma Schweiz AG
Since 1930 · 101–500 empl.3.8(34)
SCHOTT Pharma Schweiz AG is a company that provides drug containment and delivery solutions for injectable medicines. Its portfolio includes primary pharmaceutical containers such as prefillable syringes, cartridges, vials and ampoules, together with analytical, fill‑and‑finish and regulatory services.
Biosynth AG
Since 2007 · 51–100 empl.3.5(4)
Biosynth AG supplies research products, specialty chemicals, and biotechnology services for the life science, diagnostics, and pharmaceutical sectors. Its offering includes complex chemicals, peptides, biologics, enzymes, and custom synthesis and manufacturing services.
M. Opitz & Co. AG
Since 1965 · 11–20 empl.
The core activity of M. Opitz & Co. AG is the development, manufacture and marketing of cosmetic products. The company offers contract manufacturing, quality assurance, packaging and research & development for cosmetic products, with a strong focus on sustainability and environmental protection.
Elixan Aromatica GmbH
Since 1995 · 1–10 empl.
The core activity of Elixan Aromatica Pharma GmbH is the manufacture and distribution of aromatherapy products, essential oils, phytopharmaceuticals and medicinal products. The company also offers private-label solutions, where it manufactures products for other companies and equips them with the label and packaging of the client.
Powervet GmbH
Since 1997 · 1–10 empl.
The core activity of Powervet GmbH is the development, manufacture and marketing of natural remedies and plant-based products for animals, particularly pets, with the aim of offering gentle and natural therapy solutions.
Teva Pharmaceuticals International GmbH
Since 2000 · 51–100 empl.
Teva Pharmaceuticals International GmbH is a pharmaceutical company that develops, manufactures and markets generic and biopharmaceutical medicines. Its operations include research and development across multiple therapeutic areas and global supply‑chain and production activities.
SWISS CAPS AG
Since 2002 · 51–100 empl.
SWISS CAPS AG develops, manufactures and analytically tests pharmaceutical softgel capsules and provides manufacturing services for OEB 1–5, including controlled substances. Its services include analytical testing, formulation and process development, product transfer, packaging (e.g. blistering with serialization) and quality/regulatory support.
apimedi GmbH
Since 2005 · 1–10 empl.
The core activity of apimedi GmbH is commercial beekeeping, the production and distribution of bee products, such as honey, as well as the implementation of beekeeping training courses.
VAMEDIS Swiss GmbH
Since 2006 · 21–50 empl.
VAMEDIS Swiss GmbH is a service provider and specialist distributor in pharmaceuticals and medical devices. The company supports pharmacies, hospital pharmacies and physicians with the procurement and supply of medicines, medical devices, and related logistics and service solutions, especially for therapies for chronic and serious diseases.
miVital AG
Since 2006 · 11–20 empl.
The core activity of miVital AG is the development and manufacture of micellized active ingredients for the pharmaceutical industry. Through a patented process, poorly soluble substances are packaged with a water-soluble coating to increase the bioavailability of fat-soluble substances. The company offers individual development orders and delivery of basic solubilizers to optimize customer benefits for specific target segments.
Gonadosan GmbH
Since 2009 · 1–10 empl.
Gonadosan GmbH markets the Fertilovit brand of dietary supplements that support fertility, pregnancy and breastfeeding. The product range includes targeted formulations for women and men, including preparations for PCOS, Hashimoto, endometriosis and limited semen quality.
Vifor Fresenius Medical Care Renal Pharma Ltd.
Since 2010 · 21–50 empl.
Vifor Fresenius Medical Care Renal Pharma Ltd. develops and markets pharmaceutical products focused on iron deficiency and nephrology. The company is also involved in the development, manufacturing, and commercialization of therapies for kidney disease and iron metabolism disorders.
SwissEnergy Pharma GmbH
Since 2012 · 1–10 empl.
SwissEnergy Pharma GmbH develops and markets food supplements, including vitamins, minerals, probiotics and vitamin-containing cosmetic products. Product forms include effervescent tablets, sustained‑release capsules, lozenges, gummies and functional drinks. Manufacturing follows international quality standards and the brand is a member of GLOBAL SWISS GROUP.
Neovii Pharmaceuticals AG
Since 2013 · 21–50 empl.
Neovii Pharmaceuticals AG is an independent global biopharmaceutical company that develops and brings to market polyclonal antibody immunosuppressive therapies. Its research and products focus on transplantation medicine, stem cell transplantation, and hematology/oncology and immune disorders; the product range includes Grafalon®.
PATHELEN HEALTH CARE AG
Since 2014 · 1–10 empl.
PATHELEN HEALTH CARE AG is a biotechnology company that develops therapies for wound care and infection management, focusing on materials that physically adsorb wound exudate and address biofilms and resistant pathogens. Its portfolio includes the product PATHELEN® HYBRID and further developments such as a gel for chronic wound aftercare and a suspension for treating cystitis caused by resistant germs.
Streuli Tiergesundheit AG
Since 2017 · 21–50 empl.
The core activity of Streuli Tiergesundheit AG is the supply of Swiss veterinary clinics and veterinary practices with medicinal products, practice consumables, feed supplements, care products and biocides.
VITA24 AG
Since 2017 · 1–10 empl.
VITA24 AG operates an online shop offering dietary supplements, health products and self-tests. The assortment includes categories such as basic nutrition, nervous system & mental health, immune support and muscle care, and the company provides order fulfilment and customer support.
Plus Chemicals, Zweigniederlassung der Teva Pharmaceuticals International GmbH
Since 2018 · 51–100 empl.
Plus Chemicals, Zweigniederlassung der Teva Pharmaceuticals International GmbH develops, manufactures and sells pharmaceutical products as part of the Teva group. The website presents it as part of Teva Switzerland and describes Teva’s focus on generics and biopharmaceuticals.
Bioviida Ventures GmbH
Since 2019 · 21–50 empl.
Neovii Biopharmaceuticals GmbH is a biopharmaceutical company that develops and markets polyclonal antibody therapies for transplantation medicine and hematology/oncology. The company supports research in solid-organ and stem-cell transplantation, immune disorders and hemato-oncological conditions, and its portfolio includes the polyclonal antibody product Grafalon®.
Teva Capital Services Switzerland, Zweigniederlassung der Teva Pharmaceuticals International GmbH
Since 2021 · 51–100 empl.
Teva Capital Services Switzerland, Zweigniederlassung der Teva Pharmaceuticals International GmbH is part of Teva and belongs to the pharmaceutical group. The website describes Teva as a company that develops, manufactures and sells generic, biopharmaceutical and other medicinal products.
Travere Therapeutics Switzerland GmbH
Since 2021 · 1–10 empl.
Travere Therapeutics develops and distributes innovative therapies for rare diseases, particularly IgA Nephropathy (IgAN), Focal Segmental Glomerulosclerosis (FSGS), Classical Homocystinuria (HCU), and Cystinuria.
Sigma-Aldrich International GmbH
Since 1999 · 1–10 empl.
Sigma-Aldrich International GmbH provides products, services and expertise for life science research, biopharmaceutical development and manufacturing. Its portfolio includes chemicals, biochemicals, laboratory consumables, analytical products and solutions for water purification, filtration and cell culture.
CRAZYPETS GmbH
Since 2017 · 1–10 empl.
The core activity of CRAZYPETS GmbH is the development and implementation of private label product ranges for dogs and cats, particularly in the areas of: Anti-parasitic and biocidal products, Oral care, Skin and coat care, Dietary supplements, Environmental hygiene. The company supports customers in developing products and product ranges tailored to their specific needs and offers services such as product development, packaging design and labeling.
Streuli Pharma AG
Since 1970 · 101–500 empl.2.8(30)
The core activity of Streuli Pharma AG is the manufacture and development of medicines for the areas of human, dental and veterinary use.
ENWOTEC AG
Since 2022 · 1–10 empl.
The core activity of ENWOTEC AG is the development and provision of filtration solutions and products for various industries, including water treatment, biotechnology, food and beverage, chemicals, plasmapheresis, cosmetics, flavors and fragrances, as well as cannabis. The company offers a wide range of filtration products, including filter cartridges, functional granulates, functional membranes, depth filter pads, lens modules, activated carbon filter paper, and single-use solutions. In addition, ENWOTEC AG provides consulting services for the optimization of filtration processes.
UniMedico AG
Since 2025 · 1–10 empl.
UniMedico AG supplies import medicines, medical devices and contrast agents for radiology, along with related services for pharmacies, healthcare institutions and wholesalers. The company focuses on service, quality and reliable supply.
FormuLAB GmbH
Since 2009 · 1–10 empl.
The core activity of FormuLAB GmbH is the development and manufacture of food supplements, cosmetics and pharmaceuticals on a contract basis for pharmacies and drugstores. The company offers comprehensive services, from recipe development and raw material procurement to production, packaging and labeling of the final products.
ITNOA Pharmaceuticals GmbH
Since 2024 · 1–10 empl.
ITNOA Pharmaceuticals GmbH distributes pharmaceutical products and supplies medicines to healthcare providers and partners. The company states it works with manufacturers and healthcare partners to provide medicines that meet safety and effectiveness standards.
BETEC AG
Since 2025 · 1–10 empl.
BETEC AG develops and supplies machines and systems for the chemical, pharmaceutical, and food industries. The company focuses on tailored solutions that improve efficiency and production processes.
Terra Rhenus pharmaceutics AG
Since 2020 · 1–10 empl.
Tripharma AG
Since 1960 · 1–10 empl.
Regisana Naturheilmittel, M. Friz
Since 1985 · 1–10 empl.
HejSano AG
Since 1990 · 1–10 empl.
MT Beteiligungs AG
Since 1999 · 1–10 empl.
IN-FLUENCE AG
Since 2007 · 1–10 empl.
Alpinia Institute for Life Sciences AG
Since 2008 · 1–10 empl.
ROGOPHARM GmbH
Since 2008 · 1–10 empl.
Pharmapool-Logistic AG
Since 2008 · 1–10 empl.
Immo-Med AG
Since 2010 · 1–10 empl.
Bichsel AG
Since 2014 · 1–10 empl.
NABIS Mario Boscardin
Since 2018 · 1–10 empl.
ITV INNOTECH VERTRIEBS AG
Since 2020 · 1–10 empl.
Swiss Micelle AG
Since 2020 · 1–10 empl.
Humion AG
Since 2023 · 1–10 empl.
TopSwiss AG
Since 2024 · 1–10 empl.
Qmona AG
Since 2025 · 1–10 empl.
Avelion AG
Since 2026 · 1–10 empl.
Pharmaceutical Industry in the Canton of St. Gallen
Pharmaceutical Industry in the region
Point size by number of companies per place.
Source: commercial register (Zefix) · as of October 10, 2026
Pharmaceutical Industry in other places
By canton